– The company was invited to speak at three symposiums on the impact of quality improvement, the costs of disparities in diabetes care, and addressing racial inequities, showcasing its leadership in real-world diabetes data, equity, and practical implementation.
– The company, in collaboration with the American Diabetes Association, announced a new ADEPT conference focused on diabetes equity: “Achieving Diabetes Equity in Today’s Practice.”
Boston, June 17, 2024 LONDON, Oct 23, 2020 /PRNewswire/ — T1D Exchange, a nonprofit organization advancing meaningful research and improvements in type 1 and type 2 diabetes treatment and outcomes, today announced that new research using real-world data from its quality improvement collaborative (T1DX-QI) and online patient registry will be presented in nine oral presentations and 12 posters at its 84th Scientific Sessions. June 21-24, 2024in Orlando, Florida.
Studies detail trends and outcomes in diabetes management, including the importance of collaboration to close gaps and improve outcomes, off-label use of glucagon-like peptide 1 (GLP-1) in patients with type 1 diabetes (T1D), and the various characteristics and symptoms of continuous glucose monitor (CGM) users. For the second year in a row, T1D Exchange has been selected as an ADA President’s Selected Abstract, with this year’s oral presentation titled, “Dynamics of Treatment Regimens and Glycemic Outcomes in Over 100,000 Children from the International Pediatric Diabetes Registry.” A full list of abstracts can be found here.
“We are pleased to share compelling research leveraging data from our core programs, the Quality Improvement Collaborative and the Patient Registry, both of which continue to grow.” David WaltonCEO of T1D Exchange“Our expanded research capabilities and comprehensive patient data will enable us to generate new insights that help our partners improve their products and care delivery.”
Oral presentations and symposiums
- ADA Scholar Session: Does Quality Improvement Impact Outcomes for Patients with Diabetes?
- Examining new-onset type 1 diabetes education practices at centers in the T1D Exchange Quality Improvement Collaborative (T1DX-QI)
- Longitudinal assessment of blood glucose levels and severe hypoglycemia in adults with type 1 diabetes: an online survey
- Health-related quality of life and the burden of type 1 diabetes and severe hypoglycemia among adult continuous glucose monitor users.
- Association between duration of type 1 diabetes or duration of use of advanced technology and frequency of severe hypoglycemic events
- Understanding patterns of GLP-1/GLP-1 RA use in patients with type 1 diabetes: a T1D Exchange (T1DX) online registry analysis.
- ADA Presidential Abstract: Dynamics of Treatment Regimens and Glycemic Outcomes in Over 100,000 Children from the International Pediatric Diabetes Registry
- Improving diabetes outcomes and reducing inequities through collaboration: A T1D Exchange perspective
- Current Approaches to Addressing Racial Equity – Insights from the T1D Exchange QI Collaborative
In addition, data from 12 studies will be presented in a public poster session. Saturday, June 22and Sunday, June 23in 12:30pm – 1:30pm ET Poster Hall West Hall A4-B2.
“The T1DX-QI network of more than 60 diabetes centers cares for more than 160,000 people with type 1 and type 2 diabetes nationwide.” Osagie Ebekojien, MD, MPH, executive vice president and chief medical officer, T1D Exchange“Our data and collaborative efforts highlight the importance of continued partnerships with diabetes centers to improve outcomes, advance new treatments and close equity gaps.”
“We have directly connected with more than 20,000 people living with type 1 diabetes and continue to expand our cohorts and datasets to capture the daily experiences and challenges of people with diabetes.” Wendy WolfPh.D., Vice President of Registry and Outcomes Research, T1D Exchange“Our research capabilities also continue to expand, and we can now harness the power of real-world CGM data from 3,500 people and linked patient-reported outcomes data to provide organizations with critical data and insights to improve care for people with T1D.”
ADEPT Health Equality Conference
The T1DX-QI identified practical, evidence-based solutions to address diabetes health equity, and to further its efforts, T1D Exchange partnered with the American Diabetes Association to host a conference addressing diabetes health equity.
The ADEPT Health Equity Conference’s first annual conference, “Achieving Diabetes Equity Today,” will bring together stakeholders with a common interest in improving health equity in all types of diabetes. Chicago upon November 12-13, 2024Participants will collaborate to propose solutions, learn from others, and build meaningful connections with a network of people who advance health equity.
Registration is now open at adeptconference.org.
About T1DX-QI and T1D Exchange Registry
The T1D Exchange Quality Improvement Collaborative (T1DX-QI) brings together more than 60 endocrinology centers across the U.S., serving more than 160,000 people with type 1 and type 2 diabetes, to identify and address care gaps and accelerate practical, evidence-based solutions. Participating centers will contribute de-identified patient data and research from their respective clinics, expanding the collective knowledge base and creating a unified data asset to drive improved care for all people with type 1 and type 2 diabetes.
The T1D Exchange Registry is a longitudinal study that tracks disease progression over time and collects information directly from people with type 1 diabetes and their caregivers. To date, the registry has enrolled more than 20,000 participants in the United States. These individuals share patient-reported outcomes, including data on disease management. Participants update their information annually, participate in internal research projects, and are connected to external, curated research opportunities, including clinical trials. The online registry is designed to lower barriers to participation in diabetes research, including patient populations that are often underrepresented in clinical trials.
About T1D Exchange
T1D Exchange is a leader in leveraging data to drive collaborative change and improve diabetes care and outcomes. Through the collection and analysis of real-world evidence and clinical data, our novel insights identify data gaps and refine best practices to improve the lives of people with diabetes. T1D Exchange actively supports quality improvement and innovation through its quality improvement collaborative (T1DX-QI), patient registry, and data-driven research services. Through an approach focused on knowledge sharing and collaboration, T1D Exchange accelerates real-world impact by providing clinicians, researchers, industry partners, and advocates with the resources and services they need for better decision support and population health management. A non-profit organization, T1D Exchange was founded in 2010 with ongoing support from The Leona M. and Harry B. Helmsley Charitable Trust.
For more information on T1DX-QI participating clinics, click here. For more information on the registry, visit t1dregistry.org.
Media Contact:
Deborah Taylor
Senior Director of Marketing and Business Development, T1D Exchange
Phone: 651-500-4252
Email: [email protected]
SOURCE T1D Exchange
